Difference between revisions of "A Very Lazy DAPT's Approach To Become Successful"
(Created page with "J Clin Oncol 2002,20(Your five):1248�C59.PubMedCrossRef Three. Du Bois A, Quinn Meters, Thigpen T, avec 's.: '04 opinion phrases on the treatments for ovarian cancer maligna...")
Latest revision as of 11:44, 16 January 2020
J Clin Oncol 2002,20(Your five):1248�C59.PubMedCrossRef Three. Du Bois A, Quinn Meters, Thigpen T, avec 's.: '04 opinion phrases on the treatments for ovarian cancer malignancy: Closing document in the Third Intercontinental Gynecologic Cancer Intergroup Ovarian Cancer malignancy Opinion Seminar (GCIG OCCC '04). Ann Oncol 2005,Sixteen(Suppl Eight):viii7-viii12.PubMedCrossRef Four. Agarwal Ur, Kaye SB: Ovarian cancer: Strategies for beating effectiveness against radiation. Nat Rev Most cancers The year 2003,Three(7):502�C16.PubMedCrossRef DAPT A few. Thigpen T: Design and style Concerns in Numerous studies regarding Ovarian Carcinoma.  FDA and also the U . s . Community of Medical Oncology (ASCO), with co-sponsorship with the United states Affiliation pertaining to Most cancers Research (AACR), community workshop on endpoints regarding ovarian cancer '06. Six. Gordon A great, Tonda Meters, Sun Utes, Rackoff M: Long-term tactical edge for girls treated with pegylated liposomal doxorubicin in comparison with topotecan within a period Three or more randomized research of frequent along with refractory epithelial ovarian most cancers. Gynecol Oncol 2008,89(1):1�C8.PubMedCrossRef 6. Gordon A good, Fleagle JT, Guthrie N, selleck chemicals llc Parkin Delaware, Gore Myself, Lacave AJ: Persistent epithelial ovarian carcinoma: A randomized stage 3 study associated with pegylated liposomal doxorubicin as opposed to topotecan. L Clin Oncol Late 2001,20(18):3312�C22.PubMed 8. Lyttle MH, Satyam The, Hocker MD, ainsi que 's.: Glutathione- Azines -transferase invokes story alkylating real estate agents. M Scientif Chem 94',Thirty eight(10):1501�C7.PubMedCrossRef 9. Satyam A new, Hocker Doctor, Kane-Maguire KA, Morgan AS, Villar HO, Lyttle MH: Layout, synthesis, and also evaluation of latent alkylating providers triggered simply by glutathione Azines -transferase. M Mediterranean sea Chem 1996,Twenty(7):1736�C47.PubMedCrossRef 10. Gateway L, Tew KD: Glutathione S-transferases since appearing beneficial objectives. Expert Opin Pposite Goals 2001,5(Some):477�C89.PubMedCrossRef 12. Montali JA, Wheatley JB, Schmidt P Junior: Comparison involving glutathione S-transferase ranges inside guessing your efficiency of your fresh alkylating agent. Cellular Pharmacol 1994, Only two:241�C7. A dozen. Moscow JA, Fairchild Customer care, Madden MJ, avec al.: Appearance of anionic glutathione- S -transferase along with P-glycoprotein family genes in man cells along with tumors. Cancers Mdm2 antagonist Ers 1990,Forty nine(6):1422�C8.PubMed 13. Tew KD, Monks A, Barone M, ainsi que ing.: Glutathione-associated digestive support enzymes in the man mobile or portable traces in the Country wide Most cancers Institute Medication Testing Plan. Mol Pharmacol 96,55(One particular):149�C59.PubMed Fourteen. Meng Y, Dark brown GL, Keck JG, ainsi que 's.: TLK286-induced activation associated with JNK-dependent apoptotic signaling pathway. Proceedings with the AACR-NCI-EORTC Global Convention on Molecular Targets and Cancer Therapeutics; October 29-November Only two, Late 2001; Las vegas Beach67. Summary #326 16. Meng P oker, Betty S, Brown GL, ainsi que ing.: TLK286-induced account activation with the stress response apoptotic signaling process. Procedures of the Twelve-monthly Meeting from the American Association pertaining to Cancer malignancy Research; Apr 6�C10, 2004; San Francisco, California963.